Pantozol (Pantoprazole)

Pantoprazole, the active ingredient in Pantozol, is a proton pump inhibitor presented as an oral tablet for prescription use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease and as part of Helicobacter pylori eradication regimens.

GNH USA supplies Pantozol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole acts on the gastric proton pump to lower acid secretion, making it useful for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): reduces acid exposure, relieving heartburn and regurgitation. - Erosive esophagitis: promotes healing of inflamed esophageal tissue by decreasing gastric acidity. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence through acid suppression. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotics by creating a less acidic gastric environment.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Constipation

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis, Stevens‑Johnson syndrome) - Clostridium difficile‑associated diarrhea - Hypomagnesemia with prolonged use - Elevated liver enzymes or hepatitis - Acute pancreatitis - Interstitial nephritis or renal impairment

When prescribing Pantoprazole, consider the following safety measures. - Renal function assessment: adjust use in patients with severe renal impairment. - Hepatic impairment: monitor liver function, especially in extensive therapy. - Magnesium monitoring: check serum magnesium during long‑term treatment. - Rebound acid hypersecretion: avoid abrupt discontinuation after prolonged use. - Pregnancy and lactation: use only if potential benefit justifies the potential risk. - Store at room temperature: keep in the original packaging, protect from moisture.

Pantoprazole may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased antiviral exposure. - Methotrexate: reduced clearance, risk of toxicity.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels. - Phenytoin: decreased anticonvulsant concentrations. - Iron supplements: diminished iron absorption.